Carestream Demos New DBT Features
Carestream to demo new capabilities to its digital breast tomosynthesis module at RSNA 2014.
Carestream at RSNA 2014 will highlight new capabilities to its digital breast tomosynthesis (DBT) module.
New features include a DBT image map, improved workflow settings, and the display of DICOM-compliant 2D synthetic views calculated from the 3D dataset, Carestream said. The use of 2D synthetic views is an alternate approach that can help reduce the need for additional imaging exams and still allow for the benefits of DBT, Carestream said.
Carestream will debut a work-in-progress feature that allows the user to adjust the slab thickness of a tomosynthesis series. This capability, Carestream said, has reportedly been helpful for radiologists by helping visualize calcifications and may decrease reading time.
The Carestream Vue Mammo Workstation can display DBT exams from a variety of DICOM-compliant acquisition devices.
[[{"type":"media","view_mode":"media_crop","fid":"29538","attributes":{"alt":"Carestream Vue Mammo Workstation","class":"media-image","id":"media_crop_117153324923","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3055","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 295px; width: 439px; border-width: 0px; border-style: solid; margin: 1px;","title":"Carestream Vue Mammo Workstation","typeof":"foaf:Image"}}]]
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
